Key result
Suspected anabolic steroid use among competitive powerlifters was associated with a higher 12-year mortality compared to population controls (12.9% vs 3.1%; RR 4.6; 95% CI 2.04-10.45; p=0.0002).
Why the study?
Does suspected anabolic steroid use increase premature mortality in male competitive powerlifters?
Population
1,156 males, comprising 62 competitive powerlifters strongly suspected to have used anabolic steroids, and…
Comparison
Suspected use of anabolic steroids for… vs Population controls (n=1,094).
Design
Cohort
Follow-up
12 years
Authors
Loading...
Supports clinical caution when counseling powerlifters; leaves open whether anabolic steroids are causal.
Cohort (n=1,156)
Does suspected anabolic steroid use increase premature mortality in male competitive powerlifters?
Relative Risk: 4.6 (95% CI 2.04–10.45)
Absolute Event Rate: 12.9% vs 3.1%
p-value: p=0.0002
Suspected anabolic steroid abuse in competitive powerlifters is associated with a 4.6-fold increased risk of premature death over 12 years compared to the general population.
Pärssinen et al. (2000) conducted a cohort in Suspected anabolic steroid use (n=1,156). Suspected anabolic steroid use vs. Population controls was evaluated on Mortality (RR 4.6, 95% CI 2.04-10.45, p=0.0002). Suspected anabolic steroid use among competitive powerlifters was associated with a higher 12-year mortality compared to population controls (12.9% vs 3.1%; RR 4.6; 95% CI 2.04-10.45; p=0.0002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: